Literature DB >> 20583435

May the method of hepatic parenchymal transection influence early results of liver surgery?

Isidoro Di Carlo1, Elia Pulvirenti, Adriana Toro, Maurizio Mannino, Monica Zisa, Giulio Reale.   

Abstract

BACKGROUND/AIMS: Aim of this work was to analyze retrospectively two groups of patients who underwent hepatic resection using two different techniques, to determine whether exists a difference in hepatic tolerance and in the early outcome.
METHODOLOGY: We retrospectively analyzed seventy-one patients divided into group 1, treated with kellyclasia and Pringle maneuver, and group 2 treated with a radiofrequency device. The following parameters were analyzed: age; sex; type of disease, number of major/minor resections; total operative time and transection time; number and time of clampings; blood loss; pre- and postoperative transaminases and total bilirubin; length of hospitalization; morbidity and mortality.
RESULTS: Median total operative time and median hospital stay were similar in both groups but median median blood loss was higher in group 1. ALT levels in group 1 were higher than in group 2. Morbidity and mortality were observed only in group 1.
CONCLUSIONS: Kelly-crush is related to a lower parenchymal tolerance as shown by the higher increase in postoperative alanine aminotransferase levels.

Entities:  

Mesh:

Year:  2010        PMID: 20583435

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  A standard definition of major hepatectomy: resection of four or more liver segments.

Authors:  Srinevas K Reddy; Andrew S Barbas; Ryan S Turley; Jennifer L Steel; Allan Tsung; J Wallis Marsh; David A Geller; Bryan M Clary
Journal:  HPB (Oxford)       Date:  2011-07       Impact factor: 3.647

2.  What are the True Advantages of Devices for Hepatic Parenchymal Transection in Open Surgery?

Authors:  Isidoro Di Carlo; Adriana Toro; Annalisa Ardiri; Gaetano Bertino
Journal:  World J Surg       Date:  2015-12       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.